Скачать или смотреть Pulling the Molecular Thread Through Pediatric Thrombocytopenia, MDS and AML

Recorded January 8, 2024

This RUNX1 Research Program medical education webinar explores diagnostic and management approaches for pediatric thrombocytopenia, myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). The presenters highlight how to distinguish between immune and inherited causes of thrombocytopenia, when to suspect germline predisposition in bone marrow failure/MDS, and how comprehensive molecular profiling informs AML risk and treatment decisions.

Learning Objectives

• Understand accurate diagnosis and management of pediatric thrombocytopenia.
• Recognize the diagnostic and management implications of pediatric MDS.
• Learn how molecular profiling shapes treatment strategies in pediatric AML.

Presenters

Michele Lambert, M.D., M.S.T.R. — Associate Professor of Pediatrics; Director, Platelet Disorder Program; Medical Director, Special Coagulation Lab, Children’s Hospital of Philadelphia

Timothy S. Olson, M.D., Ph.D. — Associate Professor of Pediatrics; Medical Director, Blood & Marrow Transplant Program; Director of Research, Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia

Tanja Andrea Gruber, M.D., Ph.D. — Chambers Family Endowed Professor for Pediatric Cancer, Stanford School of Medicine; Division Chief, Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine; Director, Bass Center for Childhood Cancer and Blood Diseases, Lucile Packard Children’s Hospital – Stanford